TerrAscend (TSNDF) EBITDA Margin (QoQ) (2021 - 2026)
TerrAscend (TSNDF) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.49 Bn | 43.53 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn |
| 3 | Zoetis | 32.32 Bn | 30.65 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | TerrAscend | 194.90 Mn | 152.78 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.00 |
| Mar 31, 2026 | 599.00 |
| Dec 31, 2025 | -553.00 |
| Sep 30, 2025 | 24.00 |
| Jun 30, 2025 | -216.00 |
| Mar 31, 2025 | 148.00 |
| Dec 31, 2024 | 643.00 |
| Sep 30, 2024 | -470.00 |
| Jun 30, 2024 | 830.00 |
| Mar 31, 2024 | -1,633.00 |
| Dec 31, 2023 | 400.00 |
| Sep 30, 2023 | 1,501.00 |
| Jun 30, 2023 | -63.00 |
| Mar 31, 2023 | -1,471.00 |
| Dec 31, 2022 | 51,854.00 |
| Sep 30, 2022 | -48,035.00 |
| Jun 30, 2022 | -174.00 |
| Mar 31, 2022 | -4,960.00 |
| Dec 31, 2021 | 3,694.00 |
| Sep 30, 2021 | -2,335.00 |